Cannabis use disorder tied to 57% higher odds of suicidal thoughts in 415,000 adults
A decade of U.S. survey data links cannabis use disorder to 57% higher odds of suicidal thoughts, with women and younger adults at greater risk.
Summary
Cannabis use disorder, meaning trouble controlling cannabis use despite harm, was linked to 57% higher odds of suicidal thoughts in a study of more than 415,000 U.S. adults. The data came from the National Survey on Drug Use and Health from 2014 to 2023. The link held across age, sex and racial and ethnic groups, and was stronger in women and younger adults. It persisted after accounting for depression and psychological distress. The association did not grow stronger over the decade, even as legalization expanded and products became more potent. This is an observational association from survey data, so it cannot show that cannabis use disorder causes suicidal thoughts. The researchers also stress that the findings apply to the disorder, not to everyone who uses cannabis.
Detailed Summary
Brain and mental health are central to healthspan, and substance use disorders can shape both. A new analysis looks at how cannabis use disorder relates to suicidal thinking at a time when cannabis is more available and more potent than ever.
Researchers analyzed more than 415,000 American adults in the National Survey on Drug Use and Health, with data from 2014 to 2023. Adults with cannabis use disorder had 57% higher odds of reporting suicidal thoughts than adults without it. The study was published in the Journal of Studies on Alcohol and Drugs.
The association appeared across age groups, sexes and racial and ethnic backgrounds, though women and younger adults showed particularly elevated risk. It remained after adjusting for depression, psychological distress and other factors. Notably, the link did not strengthen over the ten years studied, despite recreational legalization in about half of U.S. states and rising product potency. The senior author said suicidal ideation does not appear to have risen among people with the disorder, but the elevated likelihood remains substantial and is not widely understood.
Practically, clinicians and individuals should treat difficulty controlling cannabis use as a possible marker of mental health risk. Screening for suicidal thoughts in people with cannabis use disorder is reasonable, and anyone struggling with control over use, or with suicidal thoughts, should seek professional help. In the U.S., the 988 Suicide and Crisis Lifeline offers support.
Several caveats apply. This is a cross-sectional survey, so the direction of the relationship is unknown: the disorder may raise risk, distress may drive problematic use, or shared factors may drive both. Self-reported data can be inaccurate. The authors stress the findings do not mean everyone who uses cannabis faces the same risk. The article does not describe a biological mechanism, and the details should be checked in the original paper.
Key Findings
- Cannabis use disorder was associated with 57% higher odds of suicidal thoughts among U.S. adults, in an observational survey analysis.
- Sample was more than 415,000 adults in the National Survey on Drug Use and Health, 2014 to 2023.
- Association held across age, sex and race/ethnicity, and was stronger in women and younger adults.
- Link persisted after adjusting for depression and psychological distress, and did not strengthen over the decade.
- Findings concern the disorder, not all cannabis use; causation and mechanism were not established.
Methodology
This is a news report on a repeated cross-sectional analysis of National Survey on Drug Use and Health data (2014 to 2023, over 415,000 adults) published in the Journal of Studies on Alcohol and Drugs. The source is a reputable peer-reviewed journal and a university research team, summarized via ScienceDaily. The evidence is observational and self-reported, so it shows association only.
Study Limitations
Cross-sectional survey data cannot establish causation or direction, and self-reporting may introduce bias. The article gives no absolute risks, confidence intervals or details on residual confounding, and the text is truncated. Check the original paper for effect sizes, adjustment methods and subgroup results.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe:
